Prevalence and Characteristics of Intimate Partner Violence Against Individuals Seeking Hematological Consultations

NCT06415968 | Terminated

• 1 other identifier: NIMAO/2023-2/JCG-01
• Study Type: observational
• Target: 138
• Locations: 1 country
• Sites: 1

Brief Summary

Intimate violence against individuals, which is particularly marked among women, is one of the most widespread human rights violations in the world. The Women Abuse Screening Tool (WAST) self-questionnaire is a screening tool validated in French. Our preliminary data describing the association between intimate violence against women and the first attack of unexplained venous thromboembolic disease, show a significant frequency of positive responses to the WAST among women attending a biological hematology consultation at the CHU de Nîmes, for reasons of hemostasis disorders (8% out of the first 200 cases). The study authors wish to establish the prevalence of this situation among patients presenting to the CHU de Nîmes for hematological exploration and management. They hypothesize that the prevalence of violence against individuals seen in Hematology consultations is higher among individuals with hemostasis pathologies (hemorrhagic and thrombotic pathologies) than those with cellular pathologies, and higher among women than men.

Conditions

Intimate Partner Violence; Deep Vein Thrombosis (DVT)/Thrombophlebitis; Pulmonary Embolism and Thrombosis

Outcome Measures

Primary Outcomes (1)

• Prevalence of patients experiencing Intimate Partner Violence according to consulting department

  Percentage of patients with a Women Abuse Screening Tool (WAST) score ≥ 5 consulting in the hemostasis pathology versus cellular hematological pathology department. The WAST is an 8-item questionnaire with a score ranging from 0 to 16 (worst violence), with a cut-off of 5 for presence of violence

  Day 0

Secondary Outcomes (4)

• Prevalence of Intimate Partner Violence in men versus women according to consulting department

  Day 0

• Prevalence of Intimate Partner Violence according to patient disease status and gender

  Day 0

• WAST questionnaire score according to patient disease status and gender

  Day 0

• Association between the major risk factors for Intimate Partner Violence and WAST score.

  Day 0

Study Arms (1)

Patients presenting at a biological hematology consultation

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Outpatients attending consultations at the CHU de Nîmes for hematological diseases.

You may qualify if:

• Currently in a relationship or has been in one in the last 12 months, regardless of the length of the relationship
• Willing to complete the anonymous WAST self-questionnaire
• able to read and understand French
• Outpatient consultant at Nîmes University Hospital in one of the following departments:
• Biological hematology consultation
• Clinical hematology consultation
• Vascular medicine consultation

You may not qualify if:

• Individuals under court protection, guardianship or curatorship
• Individuals unable to read and understand French
• Individuals who have already completed the WAST questionnaire during the study period
• Individuals unable to get away from their partner during the consultation to complete the questionnaire in isolation

Sponsors & Collaborators

• Centre Hospitalier Universitaire de Nīmes: lead

Study Sites (1)

CHU de Nimes

Nîmes, France

Location

MeSH Terms

Conditions

Venous Thrombosis; Pulmonary Embolism; Thrombosis

Condition Hierarchy (Ancestors)

Embolism and Thrombosis; Vascular Diseases; Cardiovascular Diseases; Lung Diseases; Respiratory Tract Diseases; Embolism

Study Officials

• Jean-Christophe Gris

  CHU de Nimes

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: ECOLOGIC OR COMMUNITY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 13, 2024
• First Posted: May 16, 2024
• Study Start: September 10, 2024
• Primary Completion: February 11, 2025
• Study Completion: February 11, 2025
• Last Updated: February 18, 2025

Record last verified: 2025-02

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)